JAK2 and melanoma: In particular, the most studied and commonly altered pathways in melanoma are the mitogen-activated protein kinase (MAPK), PI3K [16,17], and Janus kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) [8].